Page 438 - Libro 2

418
PART 6 — MISCELLANEOUS
46. Wang Y, Wang Y, Wang Y, et al. Intraoperative real-time contrast-enhanced ultrasound angi- ography: a new adjunct in the surgical treatment of arteriovenous malformations. Neurosurg. 2007;107:959–964.
47. Shah F, Balan P, Weinberg M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med. 2007;12(4):291–297.
48. Magnoni M, Coli S, Marrocco-Trischitta MM, et al. Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries. Eur J Echocardiogr. 2009;10: 260–264.
49. Coli S, Magnoni M, Sangiorgi G, et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol. 2008;52(3):223–230.
50. Staub D, Patel MB, Tibrewala A, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010;4(1):41–47.
51. Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999;353:1579–1583.
52. Lee KH, Choi BI, Kim KW, et al. Contrast-enhanced dynamic ultrasonography of the liver: optimization of hepatic arterial phase in normal volunteers. Abdom Imaging. 2003;28(5): 652–656.
53. Sellars ME, Sidhu PS, Heneghan M, et al. Infusions of microbubbles are more cost-effective than bolus injections in Doppler studies of the portal vein: a quantitative comparison of normal volunteers and patients with cirrhosis. Radiology. 2000;217(P):396.
54. Skjoldbye B, Weislander S, Struckmann J, et al. Doppler ultrasound assessment of TIPS patency and function- the need for echo enhancers. Acta Radiol. 1998;39:675–679.
55. Uggowitzer MM, Hausegger KA, Machan L. Echo-enhanced Doppler sonography in the evalu- ation of transjugular intrahepatic portosystemic shunts: clinical applications of a new trans- pulmonary US contrast agent. Radiology. 1996;201(P):266.
56. Missouris CG, Allen CM, Balen FG, et al. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens. 1996;14(4):519–524.
57. Needleman L. Review of a new ultrasound contrast agent: EchoGen emulsion. Appl Rad. 1997;26(S):8–12.
58. Karamehic J, Scoutt LM, Tabakovic M, et al. Ultrasonography in organs transplantation. Med Arh. 2004;58(1 suppl 2):107–108.
59. Benozzi L, Cappelli G, Granito M, et al. Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc. 2009;41(4):1214–1215.
60. Boggi U, Morelli L, Amorese G, et al. Contribution of contrast-enhanced ultrasonography to nonoperative management of segmental ischemia of the head of a pancreas graft. Am J Transplant. 2009;9(2):413–418.
61. Faccioli N, Crippa S, Bassi C, et al. Contrast-enhanced ultrasonography of the pancreas. Pancreatology. 2009;9(5):560–566.
62. Leutoff UC, Scharf J, Richter GM, et al. Use of ultrasound contrast medium Levovist in after- care of liver transplant patients: improved vascular imaging in color Doppler ultrasound. Radiology. 1998;38:399–404.
63. Sidhu PS, Shaw AS, Ellis SM, et al. Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol. 2004;14(1):21–30.
64. Giannoni MF, Palombo G, Sbarigia E, et al. Contrast-enhanced ultrasound for aortic stent- graft surveillance. J Endovasc Ther. 2003;10(2):208–217.
65. Iezzi R, Cotroneo AR, Basilico R, et al. Endoleaks after endovascular repair of abdominal aortic aneurysm: value of CEUS. Abdom Imaging. 2010;35(1):106–114.
66. Oka MA, Rubens DJ, Strang JG. Ultrasound contrast agent in evaluation of abdominal ves- sels. J Ultrasound Med. 2001;20:S84.